Exciting News: Illumina Acquires edico genome!
Announced this morning during BioIT World. I am very excited to be able to bring this technology to my customers! Quoting Susan Tousi, Senior Vice President of Product Development at Illumina:
“Our acquisition of Edico Genome is a big step toward realizing the vision of reducing sequencing data acquisition and analysis to a push-button, standardized process. We expect to build on the solid foundation of DRAGEN to deliver a more streamlined and integrated sample to answer experience for our customers.”
For more information please contact me or read the press release at: https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=2349147
_________________________________________________________________________
Bruce Windoffer is an informatics sales specialist with Illumina, helping to enable customers to decrease the informatics barriers of NGS - Next Generation Sequencing.
Market Summary > Illumina, Inc. NASDAQ: ILMN 268.84 USD +5.09 (1.93%) Closed: May 16, 4:32 PM EDT · Disclaimer After hours 268.84 0.00 (0.00%) Well done Illumina.